Delivery Order SPE2DE21D7007-SPE2D625F73K7

Award Date 12/12/24
Potential Completion Date 12/17/24
Potential Value $37K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Warsaw, IN, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D7007
    Indefinite Delivery Contract
  • SPE2DE21D7007-SPE2D625F73K7
    Delivery Order

This federal contract award, valued at $36,779.38, was issued by the Defense Logistics Agency (DLA) to Zimmer US Inc., a leading global medical device manufacturer specializing in orthopedic implants and surgical instruments. The contract is for the delivery of "REVISION FEMORALS - PERSONA" medical devices, with a completion date of December 17, 2024.

Zimmer US Inc., doing business as Zimmer Biomet, is a for-profit organization that holds a significant Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) Veterans Health Administration, valued at up to $80 million. This multiple-award Indefinite Delivery Vehicle (IDV) contract, which runs through September 14, 2028, allows VA medical facilities to efficiently procure a wide range of medical supplies, including orthopedic implants and surgical instruments.

In addition to the FSS contract, Zimmer Biomet has access to other IDIQ contract vehicles, such as the DLA Troop Support Medical IDIQ and the VA Prosthetic Implants and Appliances master IDIQ, which facilitate the procurement of medical devices to support healthcare services for veterans and military treatment facilities across various government agencies. This federal contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 3/13/25, 9:50 AM